Sumitomo Mitsui Trust Holdings, Inc. Natera, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $164 Billion
- Q4 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 711,394 shares of NTRA stock, worth $145 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
711,394
Previous 883,538
19.48%
Holding current value
$145 Million
Previous $142 Million
2.18%
% of portfolio
0.09%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding NTRA
# of Institutions
768Shares Held
126MCall Options Held
1.13MPut Options Held
417K-
Vanguard Group Inc Valley Forge, PA12.4MShares$2.53 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.9MShares$2.44 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY11.6MShares$2.38 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.38 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.25MShares$869 Million2.96% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $19.8B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...